The business of making vaccines-Reference-Cited by-同舟云学术

The business of making vaccines

Published:2005-11 Issue:11 Volume:23 Page:1359-1366
ISSN:1087-0156
Container-title:Nature Biotechnology
language:en
Short-container-title:Nat Biotechnol

Author:

Sheridan Cormac

Publisher

Springer Science and Business Media LLC

Subject

Biomedical Engineering,Molecular Medicine,Applied Microbiology and Biotechnology,Bioengineering,Biotechnology

Link

http://www.nature.com/articles/nbt1105-1359.pdf

Reference3 articles.

1. Scherer F.M. American Anti-Trust Institute Working Paper 04-03 29 (American Anti-Trust Institute, Washington, DC, October 2004). http://www.antitrustinstitute.org/recent2/351.pdf

2. Datamonitor. Commercial Perspectives: Vaccines (Datamonitor, London, January 2004).

3. Ulmer J.B. et al. Heterologous protection against influenza by infection of DNA encoding a viral protein. Science 259, 1691–1692 (1993).

Cited by 17 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The influence of institutional logics on vaccine development, production and distribution in Africa;International Journal of Operations & Production Management;2024-06-10

2. Cell-Free Synthetic Biology;Advances in Bioinformatics and Biomedical Engineering;2023-10-02

3. Direct Quantification of Protein Antigens in Subunit Plague and Rickettsial Vaccine Preparations;Problems of Particularly Dangerous Infections;2023-02-11

4. Therapeutic and Protective Potential of Mesenchymal Stem Cells, Pharmaceutical Agents and Current Vaccines Against COVID-19;Current Stem Cell Research & Therapy;2022-02

5. Stability Studies of Vaccines;Drug Stability and Chemical Kinetics;2020